Panhypopituitarism
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
57%
4 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Growth Hormone and Endothelial Function in Children
Testosterone Gel Applied to Women With Pituitary Gland Problems
Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism